CD8A and breast cancer: DEC205 receptor expressing CD8α DCs pulsed with extracellular domain peptides of the HER2/neu protein was able to generate CD4+ and CD8+ immune response and B cell-mediated antibody production in preclinical model of HER2/neu+ BC.